关于我们

我们在改善人类生命的道路上,砥砺前行。

作为一家独立的敏捷型公司,凯理斯致力于投资创新技术、为新市场提供服务和创造更多价值,从而帮助全球生物制药行业更快地为患者带来急需的医疗解决方案。

我们的使命

凯理斯致力于塑造临床研究的未来。我们拥有优秀的人才和先进的技术,为了我们的客户和他们在世界各地的患者的利益,我们不断朝着复杂的问题前进,因为他们依赖于我们所开发的医疗解决方案而生存。

凭借全球业务网、可靠的运营基础设施和深厚的科学知识,凯理斯能够应对复杂的临床开发挑战,从而帮助我们的客户更快地为需要的患者带来新的医疗解决方案。

01JAN2020-CTMS-FloatingPill

重要成果

凯理斯经验证的解决方案可用于开发新的医疗解决方案,从而使我们的客户能够为世界各地的患者带来可挽救生命和改善生活的方法。

迄今为止,凯理斯的解决方案已被用于逾 650 个获批疗法的临床开发中,让我们感到自豪的是,其中逾 70 个被指定为突破性疗法。与其他可用疗法相比,这些疗法正在为重症患者带来实质性的改善。

“在凯理斯,我们激发才智,以改善世界各地人们的生活。”

– Stephen M. Bravo, 医学博士, 凯理斯首席医学官

领导团队

我们的领导团队由不同行业和技术领域的资深人士组成,他们在推进生命科学发展方面的经验都是首屈一指的。

MEET THE SCIENTISTS
CALYX-20-Headshots-MichaelBolton-FINAL

首席财务官

Michael Bolton

Michael joined Calyx as Chief Financial Officer in April 2022, bringing a wealth of executive-level experience level in both operations and finance to the organization. Prior to joining Calyx, he worked primarily in IT-enabled service companies that provided support to US federal, state, and local governments as well as commercial entities in the US and internationally. Michael has a proven track record of helping private equity-backed, mid-market companies grow.

 

LinkedIn Profile

 

CALYX-20-Headshots-JamieMoss-FINAL_v2

首席运营官

Jamie Moss

Jamie joined Calyx in January 2020 as the Chief Operating Officer bringing deep, global experience in driving operational excellence and breakthrough financial results. His 25 years’ experience includes a variety of operations, manufacturing, and senior executive roles across the aerospace, engineering, and professional services sectors. Jamie is a Chartered Engineer and holds an MBA from the University of Warwick Business School.

 

LinkedIn Profile

 

CALYX-20-Headshots-StephenBravo-FINAL

首席医疗官

Stephen M. Bravo,医学博士

Stephen Bravo, MD joined Calyx in March 2021, bringing more than 30 years of broad scientific experience to the organization. 其专业知识来源于在备受赞誉的医疗保健中心担任经委员会认证的放射科诊断医生、在顶尖学术机构担任高级教员,以及在众多全球制药公司担任值得信赖的科学顾问。An acknowledged expert in Neuroradiology, Musculoskeletal Radiology, and Interventional Radiology, Dr. Bravo has authored numerous publications and abstracts, holds licenses in three states, and has undertaken the role of principal investigator in over 100 clinical trials.

 

LinkedIn Profile

 

CALYX-20-Headshots-MichelleRonan-FINAL

首席策略官

Michelle Ronan

Michelle Ronan joined Calyx in April 2022, bringing expertise in developing and executing long-term strategic plans in the global eClinical market. She is an accomplished Head of Corporate Strategy and Development, with significant experience centred around private equity backed businesses, guiding teams through the different stages of a business’ lifecycle. Prior to joining the organization, Michelle consulted with Calyx, identifying opportunities for creating value and driving growth for the business.

CALYX-20-Headshots-JohnBlakely-FINAL

首席商务官

John Blakeley

John Blakeley joined Calyx as Chief Commercial Officer in January 2020 and brings more than 30 years of senior commercial leadership experience. His expertise in the eClinical solutions space stems from having held C-suite positions at CRF Health, Greenphire, and ERT. John is a seasoned and innovative sales leader who has a successful track record in building high-performing teams to develop creative clinical solutions for customers and drive revenue growth.

 

LinkedIn Profile

 

CALYX-20-Headshots-PurveshPatel-FINAL_v1

法律总顾问兼首席合规官

Purvesh Patel

Purvesh Patel joined Calyx in November 2020 leading the Legal, Compliance, Quality, Information Security, Data Privacy and Corporate Development functions. He has nearly 20 years of in-house legal and international corporate transactions experience in highly regulated health and technology sectors. Purvesh has his JD from Case Western Reserve University School of Law and is a trusted business partner relied on by C-suite leaders and Boards to advise on strategic planning, managed growth and governance on a global scale.

 

LinkedIn Profile

 

CALYX-20-Headshots-Shelley-FINAL

首席人力官

Shelley Latham

Shelley Latham joined Calyx as Chief People Officer in January 2020 and brings 25 years of experience leading human resources across a broad range of organizations. Prior to joining Calyx, she served as CHRO at Health Trust Europe LLP and held various senior HR positions at Southern Cross Health Care and Beacon Entertainment. Shelley is a Chartered Member of the Institute of Personnel Development and holds an MBA from Nottingham Business School.

 

LinkedIn Profile

 

Richard Wallace 担任凯理斯的首席数字和战略官

首席数字与信息官

Richard Wallace

Richard Wallace joined Calyx as Chief Digital Information Officer in February 2021, bringing a wealth of experience from having established and implemented successful business and technology strategies across multiple organizations. Prior to joining Calyx, Richard was Global CIO of Kantar Media & Worldpanel (WPP Group) and has led several R&D transformation projects at IAG / British Airways, G4S & Santander. Richard holds a degree in Economics from the University of Newcastle and an Executive Diploma from the Saïd Business School, University of Oxford.

 

LinkedIn Profile

 

Meet the scientists

将凯理斯资深科学专家的深厚和多样的经验带到您的临床开发团队。

CALYX-20-Headshots-PeterSteiger-FINAL

首席科学官

Peter Steiger,博士

Peter 在利用影像和其他生物标志物记录临床试验新药的安全性、疗效和有效性方面拥有丰富的经验。他带领由逾 75 名科学家组成的凯理斯全球科学和医疗服务团队,并积极参与开发和实施适用于全球临床开发项目的高效影像策略。他著作了多篇论文,并定期参加科学会议上提出的研究。

 

LinkedIn Profile

CALYX-20-Headshots-Oliver-FINAL

Vice President, Medical Imaging & Head of Oncology

Oliver Bohnsack,医学博士、博士、工商管理硕士

在引导凯理斯全球客户的肿瘤学研究的影像工作方面,Oliver 利用其在支持逾 600 项临床试验后获得的经验,其中这些试验涵盖各种不同的适应症、复杂情况并处于开发的各个阶段,他的经验致使逾 20 种肿瘤治疗获得批准。他是《免疫相关疗效标准》(irRC,2009 年)的共同作者、《免疫相关实体瘤疗效评价标准》(irRECIST,2014 年)的第一作者、Eggleton P. 等人《对根据实体瘤疗效评价标准 (RECIST) 与 irRECIST 进行的评价的比较》(2020 年)的共同作者。

 

LinkedIn Profile

CALYX-20-Headshots-Surabhi-FINAL

Associate Director, Medical Imaging

Surabhi Bajpai,医学博士

利用在医学和放射学方面接受过的培训,Surabhi 主导了约 50 项肿瘤学试验(包括实体瘤和血液学恶性肿瘤)的影像部分,并就标准化疗效评估标准的复杂方面提供了咨询。她在多发性骨髓瘤、淋巴瘤和慢性淋巴细胞性白血病 (CLL) 方面的专业知识让她能够为临床试验申办方提供明确的指导,并告知独立审核人关于标准的复杂性,以免产生异质性。

 

LinkedIn Profile

CALYX-20-Headshots-ManishSharma-FINAL

Vice President, Medical Imaging

Manish Sharma, MD DMRE

Having held senior medical roles at global biopharmaceutical companies and CROs and having worked as an investigator, Manish has a wealth of experience in understanding and executing clinical trials from each stakeholder’s perspective. Manish is a well-established medical and scientific SME for imaging in clinical trial design and execution and has been instrumental in the incorporation of innovative study designs including but not limited to biomarkers including imaging. Manish also has the additional responsibility of leading the Calyx Data Science team focusing on variability analysis, data-driven quality monitoring, and predictive analytics.

 

LinkedIn Profile

CALYX-20-Headshots-SallyWarner-FINAL

Vice President, Scientific and Medical Services

Sally (Sarah) Warner, PhD, CCD

As the Head of Calyx Musculoskeletal Imaging, Dr. Warner applies her 25+ years of medical imaging research experience and the expertise she’s gleaned from supporting over 200 imaging trials to help pharmaceutical companies and CROs succeed.  She holds certifications by the International Society for Clinical Densitometry (ISCD) as a Clinical Densitometrist and a DXA technologist as well as a Radiology Practicing Technologist License in the state of Utah.  Dr Warner’s musculoskeletal research has included the use of many different modalities for the assessment of bone metabolism including bone histomorphometry, 3-point bending, radiography, ultrasound, DXA, QCT, and high-resolution CT imaging.

 

LinkedIn Profile

Director, Scientific & Medical Services

Manuela Lesch, RT

Manuela is responsible for providing scientific advice on implementing medical imaging into clinical trials, conducting investigator, internal staff, and independent reviewer trainings, supporting the development of independent review charters, providing guidance to R&D and application development in the customization of image analysis software tools, and monitoring independent reviewer performance. Manuela has significant experience in leading and managing the imaging component of multiple neurology and oncology clinical trials, with expertise in applying neuro-oncology image assessment criteria such as RANO, iRANO, LANO, REiNS and volumetric analysis.

 

LinkedIn Profile

CALYX-20-Headshots-FarhanSyed-FINAL

Director, Scientific & Medical Services

Farhan Syed, PhD

Farhan applies his extensive training and knowledge in bone loss mechanisms and imaging ‒ both in pre-clinical and clinical settings ‒ to leading and overseeing varied clinical trials involving the musculoskeletal system. He also serves as a subject matter expert in this area, contributing and facilitating protocol reviews as well as imaging-focused discussions with clients as well as consultation and networking with Key Opinion Leaders in the field.

 

LinkedIn Profile

变幻莫测的环境

“全球化思维,本地化行动。”—— Patrick Geddes

由于临床试验日益复杂且规模扩大,而且会同时涉及全球许多不同的地区,因此与具备全球化能力和基础设施的可靠伙伴进行合作是至关重要的。

加入我们的团队

您是否乐于帮助他人?您是否希望加入一个充满先进技术的动态行业?

加入我们不断成长的团队,并享受我们提供的众多福利。联系我们,以了解您如何能够在为世界各地的患者带来改变的同时推动职业发展。

获取最新消息

不错过任何精彩内容。立即注册,接收涵盖行业新闻和其他相关信息的电子邮件,帮助您推进临床开发。

  • 此字段用于验证目的,应保持不变。
Powered by Translations.com GlobalLink OneLink Software